Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Preoperative Zoledronic Acid for the Prevention of Hungry Bone Syndrome After Parathyroidectomy in Primary Hyperparathyroidism: A Randomized Placebo-Controlled Trial. Local targets link to admitted publications; unresolved targets remain external evidence.
An Overview
10.1155/2011/251410 · 2011 · External reference
Unresolved reference
External reference
Primary hyperparathyroidism in north India: a description of 52 cases
10.5144/0256-4947.2005.29 · 2005 · External reference
Primary hyperparathyroidism: insights from the Indian PHPT registry
10.1007/s00774-017-0833-8 · 2018 · External reference
Preoperative zoledronic acid therapy prevent hungry bone syndrome in patients with primary hyperparathyroidism
10.4103/2230-8210.196023 · 2017 · External reference
Administration of pamidronate helps prevent immediate postparathyroidectomy hungry bone syndrome
10.1111/j.1440-1797.2007.00806.x · 2007 · External reference
Bisphosphonates: Mechanism of Action and Role in Clinical Practice
10.4065/83.9.1032 · 2008 · External reference
Bisphosphonate pretreatment attenuates hungry bone syndrome postoperatively in subjects with primary hyperparathyroidism
10.1007/s00774-005-0680-x · 2006 · External reference
Post-surgery severe hypocalcemia in primary hyperparathyroidism preoperatively treated with zoledronic acid
10.14310/horm.2002.1286 · 2010 · External reference
Profound and Protracted Hypophosphatemia after A Single Dose of Zoledronic Acid Infusion for Osteoporosis Associated with Normocalcemic Primary Hyperparathyroidism
10.21767/2471-8041.100059 · 2017 · External reference
THERAPY OF ENDOCRINE DISEASE: Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature
10.1530/eje-12-0528 · 2013 · External reference
Monocentric experience of primary hyperparathyroidism surgery in Algeria
10.1016/j.sopen.2021.02.002 · 2021 · External reference
Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: Data from PHPT registry
10.1007/s00774-020-01142-w · 2021 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Bisphosphonates can reduce bone hunger after parathyroidectomy in patients with primary hyperparathyroidism and osteitis fibrosa cystica
10.1590/s0482-50042011000200003 · 2011 · External reference
Role of Bisphosphonates in The Prevention of Postoperative Hungry Bone Syndrome in Primary Hyperparathyroidism: A MetaAnalysis and Need for Randomized Controlled Trials
10.1055/a-1325-0351 · 2021 · External reference
Consequences of long-term hyperparathyroidism
10.1016/s0300-2977(98)00010-2 · 1998 · External reference
10.1097/01.ten.0000257439.69010.39
10.1097/01.ten.0000257439.69010.39 · External reference
Unresolved reference
External reference
Postoperative zoledronic acid for osteoporosis in primary hyperparathyroidism: a randomized placebo-controlled study
10.1530/eje-21-0322 · 2021 · External reference
A 10-Year Prospective Study of Primary Hyperparathyroidism with or without Parathyroid Surgery
1999 · External reference
Effect of Surgery Versus Observation: Skeletal 5-Year Outcomes in a Randomized Trial of Patients With Primary HPT (the SIPH Study): EFFECT OF SURGERY VERSUS OBSERVATION IN PHPT
10.1002/jbmr.3177 · 2017 · External reference
Prediction of bone mass changes after successful parathyroidectomy using biochemical markers of bone metabolism in primary hyperparathyroidism: is it clinically useful?
10.20945/2359-3997000000154 · 2019 · External reference
Hyperparathyroid Crisis: Clinical and Pathologic Studies of 14 Patients
10.1097/00000658-197912000-00019 · 1979 · External reference
Unresolved reference
External reference
Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo
10.1359/jbmr.080617 · 2008 · External reference
International Workshop on Primary Hyperparathyroidism. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop
10.1002/jbmr.4677 · 2022 · External reference